ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL3145 |
|
257933-82-7 |
Pelitinib (Synonyms: EKB-569; WAY-EKB 569) 98+% |
C24H23ClFN5O2 | |
CL1632A |
|
439081-18-2 |
(E/Z)-Afatinib (Synonyms: (E/Z)-BIBW 2992; (S)-阿法替尼) 98+% |
C24H25ClFN5O3 | |
CL3050 |
|
133550-30-8 |
AG490 (Synonyms: Tyrphostin AG490; Tyrphostin B42) 98+% |
C17H14N2O3 | |
CL2211A |
|
1421373-66-1 |
AZD-9291 mesylate | Osimertinib mesylate | Mereletinib mesylate 98+% |
C29H37N7O5S | |
CLA1682 |
|
1826843-81-5 |
Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd) 98+% |
— | |
CL2895 |
|
937263-43-9 |
Tucatinib | Irbinitinib | ARRY-380 | ONT-380 99+% |
C26H24N8O2 | |
CLA1680 |
|
2648260-93-7 |
Becotatug | JMT-101 98+% |
— | |
CL2457 |
|
184475-35-2 |
Gefitinib | ZD1839 98+% |
C22H24ClFN4O3 | |
CL2423 |
|
183319-69-9 |
Erlotinib Hydrochloride | Erlotinib HCl 98+% |
C22H23N3O4·HCl | |
CL2220 |
|
231277-92-2 |
Lapatinib (GW572016; GW2016,Tykerb, Tyverb) 98+% |
C29H26ClFN4O4S | |
CLA1578 |
|
2171511-58-1 |
Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372) 95+% |
— | |
CLA1500 |
|
1969309-56-5 |
Anti-Human Her2xHer3 (Zenocutuzumab; MCLA-128; PB4188; R040517) 95+% |
— | |
CLA1389 |
|
1509928-04-4 |
Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005) 95+% |
— | |
CLA1314 |
|
1310460-86-6 |
Modotuximab (Anti-ERBB1 / EGFR / HER1) 95+% |
— | |
CLA1304 |
|
959963-46-3 |
Imgatuzumab (Anti-ERBB1 / EGFR / HER1) 95+% |
— | |
CLA1303 |
|
1310460-85-5 |
Futuximab 95+% |
— | |
CLA1300 |
|
1314238-96-4 |
Duligotuzumab 95+% |
— | |
CLA1295 |
|
1262787-83-6 |
Patritumab (Anti-ERBB3 / HER3) 95+% |
— | |
CLA1240 |
|
725735-28-4 |
Intetumumab 95+% |
— | |
CLA1221 |
|
906805-06-9 |
Necitumumab (anti-EGFR) 95+% |
— | |